Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus
KTH, Skolan för bioteknologi (BIO). Rutgers, The State University of New Jersey, USA.
2007 (Engelska)Ingår i: Infectious diseases in obstetrics and gynecology, ISSN 1064-7449, E-ISSN 1098-0997, Vol. 2007, s. 78248-Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Objective. To evaluate the safety of the antimicrobial peptide, lactocin 160. Methods. Lactocin 160, a product of vaginal probiotic Lactobacillus rhamnosus 160 was evaluated for toxicity and irritation. An in vitro human organotypic vaginal-ectocervical tissue model (EpiVaginal) was employed for the safety testing by determining the exposure time to reduce tissue viability to 50% (ET-50). Hemolytic activity of lactocin160 was tested using 8% of human erythrocyte suspension. Susceptibility of lactobacilli to lactocin160 was also studied. Rabbit vaginal irritation (RVI) model was used for an in vivo safety evaluation. Results. The ET-50 value was 17.5 hours for lactocin 160 (4.9 hours for nonoxynol 9, N9). Hemolytic activity of lactocin 160 was 8.2% (N9 caused total hemolysis). Lactobacilli resisted to high concentrations of peptide preparation. The RVI model revealed slight vaginal irritation. An average irritation index grade was evaluated as "none." Conclusions. Lactocin 160 showed minimal irritation and has a good potential for intravaginal application.

Ort, förlag, år, upplaga, sidor
2007. Vol. 2007, s. 78248-
Nyckelord [en]
animal experiment, animal model, antibiotic resistance, antimicrobial activity, article, cell suspension, drug delivery system, drug safety, drug screening, erythrocyte, exposure variable, female, hemolysis, intravaginal application, Lactobacillus rhamnosus, nonhuman, priority journal, rabbit, tissue characterization, tissue viability, toxicity, vagina flora, vaginal discomfort, vaginal irritation, vaginitis, animal, chemistry, comparative study, cytochemistry, drug effect, human, intravaginal drug administration, microbiological examination, pathology, vagina
Nationell ämneskategori
Annan medicin och hälsovetenskap
Identifikatorer
URN: urn:nbn:se:kth:diva-155269DOI: 10.1155/2007/78248PubMedID: 18273406Scopus ID: 2-s2.0-38749099818OAI: oai:DiVA.org:kth-155269DiVA, id: diva2:765911
Anmärkning

QC 20141125

Tillgänglig från: 2014-11-25 Skapad: 2014-11-04 Senast uppdaterad: 2017-12-05Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Sök vidare i DiVA

Av författaren/redaktören
Dover, Sara E.
Av organisationen
Skolan för bioteknologi (BIO)
I samma tidskrift
Infectious diseases in obstetrics and gynecology
Annan medicin och hälsovetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 84 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf